Literature DB >> 19750042

Medical management of Parkinson's disease.

Marvin M Goldenberg.   

Abstract

Entities:  

Year:  2008        PMID: 19750042      PMCID: PMC2730785     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


× No keyword cloud information.
  29 in total

1.  A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.

Authors: 
Journal:  Arch Neurol       Date:  2002-12

Review 2.  Parkinson's disease: background, diagnosis, and initial management.

Authors:  Roger L Albin
Journal:  Clin Geriatr Med       Date:  2006-11       Impact factor: 3.076

Review 3.  Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesias.

Authors:  Robert A Hauser
Journal:  Geriatrics       Date:  2006-09

4.  Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

Authors: 
Journal:  JAMA       Date:  2000-10-18       Impact factor: 56.272

Review 5.  LRRK2 in Parkinson's disease: protein domains and functional insights.

Authors:  Ignacio F Mata; William J Wedemeyer; Matthew J Farrer; Julie P Taylor; Kathleen A Gallo
Journal:  Trends Neurosci       Date:  2006-04-17       Impact factor: 13.837

6.  Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations.

Authors:  H M Ruottinen; U K Rinne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

Review 7.  Pharmacotherapy for Parkinson's disease.

Authors:  Jack J Chen; David M Swope
Journal:  Pharmacotherapy       Date:  2007-12       Impact factor: 4.705

8.  Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.

Authors:  Alexander Storch; Wolfgang H Jost; Peter Vieregge; Jörg Spiegel; Wolfgang Greulich; Joachim Durner; Thomas Müller; Andreas Kupsch; Henning Henningsen; Wolfgang H Oertel; Gerd Fuchs; Wilfried Kuhn; Petra Niklowitz; Rainer Koch; Birgit Herting; Heinz Reichmann
Journal:  Arch Neurol       Date:  2007-05-14

Review 9.  Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

Authors:  Penelope J Hallett; David G Standaert
Journal:  Pharmacol Ther       Date:  2004-05       Impact factor: 12.310

10.  Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.

Authors:  Alessio Di Fonzo; Cristina Tassorelli; Michele De Mari; Hsin F Chien; Joaquim Ferreira; Christan F Rohé; Giulio Riboldazzi; Angelo Antonini; Gianni Albani; Alessandro Mauro; Roberto Marconi; Giovanni Abbruzzese; Leonardo Lopiano; Emiliana Fincati; Marco Guidi; Paolo Marini; Fabrizio Stocchi; Marco Onofrj; Vincenzo Toni; Michele Tinazzi; Giovanni Fabbrini; Paolo Lamberti; Nicola Vanacore; Giuseppe Meco; Petra Leitner; Ryan J Uitti; Zbigniew K Wszolek; Thomas Gasser; Erik J Simons; Guido J Breedveld; Stefano Goldwurm; Gianni Pezzoli; Cristina Sampaio; Egberto Barbosa; Emilia Martignoni; Ben A Oostra; Vincenzo Bonifati
Journal:  Eur J Hum Genet       Date:  2006-03       Impact factor: 4.246

View more
  18 in total

1.  Non-Oral Drug Delivery in Parkinson's Disease: Current Applications and Future.

Authors:  Meliha Güneş; Sinem Yaprak Karavana
Journal:  Turk J Pharm Sci       Date:  2022-06-27

Review 2.  Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective.

Authors:  Sachchida Nand Rai; Vivek K Chaturvedi; Payal Singh; Brijesh Kumar Singh; M P Singh
Journal:  3 Biotech       Date:  2020-11-10       Impact factor: 2.406

3.  Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.

Authors:  Manju A Kurian; Yan Li; Juan Zhen; Esther Meyer; Nebula Hai; Hans-Jürgen Christen; Georg F Hoffmann; Philip Jardine; Arpad von Moers; Santosh R Mordekar; Finbar O'Callaghan; Evangeline Wassmer; Elizabeth Wraige; Christa Dietrich; Timothy Lewis; Keith Hyland; Simon Heales; Terence Sanger; Paul Gissen; Birgit E Assmann; Maarten E A Reith; Eamonn R Maher
Journal:  Lancet Neurol       Date:  2010-11-25       Impact factor: 44.182

4.  A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole.

Authors:  Ratih S I Putri; Effi Setiawati; Syifa A Aziswan; Fenny Ong; Raymond R Tjandrawinata; Liana W Susanto
Journal:  Sci Pharm       Date:  2016-11-18

5.  Deep brain stimulation for Parkinson's disease prior to L-dopa treatment: A case report.

Authors:  Domenico Servello; Christian Saleh; Alberto R Bona; Edvin Zekaj; Carlotta Zanaboni; Mauro Porta
Journal:  Surg Neurol Int       Date:  2016-11-14

Review 6.  The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.

Authors:  Shanmugam Manoharan; Gilles J Guillemin; Rajagopal Selladurai Abiramasundari; Musthafa Mohamed Essa; Mohammed Akbar; Mohammed D Akbar
Journal:  Oxid Med Cell Longev       Date:  2016-12-27       Impact factor: 6.543

Review 7.  Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms.

Authors:  Taiwo Olayemi Elufioye; Tomayo Ireti Berida; Solomon Habtemariam
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-22       Impact factor: 2.629

8.  Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.

Authors:  Jaung-Geng Lin; Chao-Jung Chen; Han-Bin Yang; Yi-Hung Chen; Shih-Ya Hung
Journal:  Int J Mol Sci       Date:  2017-08-24       Impact factor: 5.923

9.  Intraoperative Quantitative Measurements for Bradykinesia Evaluation during Deep Brain Stimulation Surgery Using Leap Motion Controller: A Pilot Study.

Authors:  Jingchao Wu; Ningbo Yu; Yang Yu; Haitao Li; Fan Wu; Yuchen Yang; Jianeng Lin; Jianda Han; Siquan Liang
Journal:  Parkinsons Dis       Date:  2021-06-15

10.  Non-Ergot Dopamine Agonists Do Not Increase the Risk of Heart Failure in Parkinson's Disease Patients: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Renato De Vecchis; Claudio Cantatrione; Damiana Mazzei; Cesare Baldi; Marco Di Maio
Journal:  J Clin Med Res       Date:  2016-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.